nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
|
Baillie, Kirsten |
|
|
5 |
3 |
p. 239-253.e5 |
artikel |
2 |
FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape
|
Mittal, Kriti |
|
|
5 |
3 |
p. 176-178 |
artikel |
3 |
How early can we treat migraine attacks? A perspective based on prodrome
|
Yuan, Hsiangkuo |
|
|
5 |
3 |
p. 179-180 |
artikel |
4 |
Imetelstat: Finally a disease-modifying treatment for lower-risk myelodysplastic syndromes?
|
Majidi, Fatemeh |
|
|
5 |
3 |
p. 184-186 |
artikel |
5 |
New evidence for flexible psilocybin dosing in patients with treatment-resistant depression
|
Aaronson, Scott T. |
|
|
5 |
3 |
p. 187-189 |
artikel |
6 |
One small STEP, one giant leap: Semaglutide in the obese phenotype of heart failure with preserved ejection fraction
|
Sato, Ryosuke |
|
|
5 |
3 |
p. 181-183 |
artikel |
7 |
Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies
|
Tessier, Anne-Julie |
|
|
5 |
3 |
p. 224-238.e5 |
artikel |
8 |
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin
|
Rosenblat, Joshua D. |
|
|
5 |
3 |
p. 190-200.e5 |
artikel |
9 |
Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
|
Darragh, Laurel B. |
|
|
5 |
3 |
p. 254-270.e8 |
artikel |
10 |
The application of HER2-ADC in future: More than expression
|
Zhou, Jiawei |
|
|
5 |
3 |
p. 173-175 |
artikel |
11 |
The resting-state brain activity signatures for addictive disorders
|
Zheng, Hui |
|
|
5 |
3 |
p. 201-223.e6 |
artikel |